Bridget-Anne Kirwan Selected Research

Therapeutics

5/2023	Clinically stable covid-19 patients presenting to acute unscheduled episodic care venues have increased risk of hospitalization: secondary analysis of a randomized control trial.
1/2022	Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
11/2021	Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial.
10/2020	Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.
3/2016	One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure.
9/2015	A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial).
3/2015	Subconjunctival injection of XG-102, a JNK inhibitor peptide, in patients with intraocular inflammation: a safety and tolerability study.
12/2011	The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design.
12/2010	Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design.
1/2007	Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bridget-Anne Kirwan Research Topics

Disease

18	Heart Failure 01/2023 - 03/2005
12	Stable Angina 05/2011 - 09/2004
9	COVID-19 05/2023 - 10/2020
7	Iron Deficiencies 01/2023 - 12/2009
6	Myocardial Infarction 07/2016 - 09/2004
6	Stroke (Strokes) 05/2011 - 03/2005
6	Coronary Disease (Coronary Heart Disease) 04/2010 - 09/2004
4	Critical Illness (Critically Ill) 01/2023 - 08/2021
3	Anemia 01/2023 - 12/2009
3	Inflammation (Inflammations) 12/2021 - 03/2015
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2007 - 03/2005
2	Thrombosis (Thrombus) 12/2021 - 11/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2016 - 03/2007
2	Transient Ischemic Attack 07/2007 - 03/2005
1	Hyperglycemia 04/2023
1	Milk Hypersensitivity (Milk Allergy) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Infections 01/2022
1	Hemorrhage 11/2021
1	Ischemic Stroke 07/2016
1	Unstable Angina 07/2016
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 07/2016
1	Wounds and Injuries (Trauma) 03/2015
1	Cachexia 12/2011
1	Body Weight (Weight, Body) 12/2010
1	Renal Insufficiency (Renal Failure) 08/2007
1	Atherosclerotic Plaque (Atheroma) 01/2007
1	Constipation 02/2006
1	Melanoma (Melanoma, Malignant) 02/2006
1	Polyuria 02/2006
1	Asthenia 02/2006
1	Hypotension (Low Blood Pressure) 02/2006
1	Neoplasms (Cancer) 02/2006
1	Muscle Cramp (Cramp) 02/2006
1	Skin Neoplasms (Skin Cancer) 02/2006
1	Erectile Dysfunction 02/2006
1	Hypertension (High Blood Pressure) 03/2005
1	Angina Pectoris 09/2004

Drug/Important Bio-Agent (IBA)

14	Nifedipine (Adalat)FDA LinkGeneric 04/2010 - 09/2004
9	ferric carboxymaltoseIBA 01/2023 - 12/2009
8	IronIBA 01/2023 - 12/2009
4	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 10/2020
4	CalciumIBA 05/2011 - 09/2004
3	Ferritins (Ferritin)IBA 12/2020 - 12/2009
3	Transferrin (beta 2 Transferrin)IBA 12/2020 - 12/2009
3	DiureticsIBA 01/2018 - 07/2007
2	Glucose (Dextrose)FDA LinkGeneric 04/2023 - 03/2007
2	crizanlizumabIBA 01/2023 - 12/2021
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 12/2009
2	P-SelectinIBA 01/2023 - 12/2021
2	AnticoagulantsIBA 01/2022 - 11/2021
2	D-JNKI-1IBA 02/2017 - 03/2015
2	HydrogelsIBA 03/2016 - 09/2015
2	AlginatesIBA 03/2016 - 09/2015
2	LipidsIBA 05/2011 - 10/2005
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2011 - 07/2007
2	Angiotensin Receptor AntagonistsIBA 05/2011 - 07/2007
2	CreatinineIBA 03/2007 - 10/2005
1	Monoclonal AntibodiesIBA 01/2023
1	Phosphates (Orthophosphate)IBA 01/2023
1	von Willebrand FactorIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	OligosaccharidesIBA 01/2022
1	Milk Proteins (Milk Protein)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021
1	apixabanIBA 11/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2020
1	Ophthalmic Solutions (Eye Drops)IBA 02/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2017
1	Lipoproteins (Lipoprotein)IBA 07/2016
1	mipomersenIBA 07/2016
1	omega-Chloroacetophenone (Mace)IBA 07/2016
1	LDL CholesterolIBA 07/2016
1	Peptides (Polypeptides)IBA 03/2015
1	Amino Acids FDA Link 03/2015
1	Vitamin K FDA Link 05/2011
1	Uric Acid (Urate)IBA 08/2007
1	Cardiac GlycosidesIBA 07/2007
1	Blood Glucose (Blood Sugar)IBA 10/2005

Therapy/Procedure

10	Therapeutics 05/2023 - 01/2007
2	Critical Care (Surgical Intensive Care) 01/2023 - 08/2021
1	Artificial Respiration (Mechanical Ventilation) 10/2020
1	Injections 03/2016
1	Percutaneous Coronary Intervention 05/2011
1	Orthopedic Procedures 07/2007